Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1418 (LINC01418) is a human long intergenic non-coding RNA (lincRNA), defined as an RNA transcript exceeding 200 nucleotides in length that does not overlap with protein-coding genes and lacks protein-coding potential[1][3][7]. Like other lincRNAs, it may participate in chromatin remodeling, transcriptional regulation, and stabilization of RNA transcripts, playing potential regulatory roles in gene expression[1][3]. However, the specific function and clinical importance of LINC01418 remain unknown in current literature, and it is not established as a therapeutic target, nor is it presently associated with disease roles or drug interactions[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1418 (LINC01418).